StockData
Ingevity Corp logo

Ingevity Corp (NGVT) stock

NGVTNYSEChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3076% above fair value
$59.28−0.74 (-1.23%)

Close on Nov 17, 2026Market cap $2.04BP/E 40.3Yield –

Earnings

Ingevity's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 24, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
$305.10M
-15.7% on a year earlier
adjusted diluted earnings per share, Q3 FY2026
$1.63
$1.52 a year earlier
Latest guidance
Issued
Nov 4, 2026 · 4 items

Quarterly results

Revenue and earnings per share from each of Ingevity's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Feb 24, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Nov 4, 2026after the close$305.10M-15.7%$1.46$1.63Release
Q2 FY2026ended Jun 30, 2026Jul 29, 2026after the close$314.10M-14.0%$1.13$1.74Release
Q1 FY2026ended Mar 31, 2026May 6, 2026after the close$258.00M-9.2%$0.65$1.15Release
Q4 FY2025ended Dec 31, 2025Feb 25, 2026after the close$255.10M–-$2.21$0.58Release
Q3 FY2025ended Sep 30, 2025Nov 5, 2025after the close$362.10M-3.9%$1.18$1.52Release
Q2 FY2025ended Jun 30, 2025Aug 4, 2025after the close$365.10M-6.5%-$4.02$1.39Release
Q1 FY2025ended Mar 31, 2025May 5, 2025after the close$284.00M-16.5%$0.56$0.99Release
Q4 FY2024ended Dec 31, 2024Jan 16, 2025before the open––––Release
Q3 FY2024ended Sep 30, 2024Oct 29, 2024after the close$376.90M-15.5%-$2.95$1.10Release
Q2 FY2024ended Jun 30, 2024Jul 31, 2024after the close$390.60M-18.9%-$7.81$1.01Release
Q1 FY2024ended Mar 31, 2024May 1, 2024after the close$340.10M-13.4%-$1.54$0.52Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Ingevity's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
net salesGAAPFY2026$1.10B–NewNov 4, 2026
net salesFY2026$1.05B – $1.15B$1.05B – $1.15BReaffirmedJul 29, 2026
adjusted EBITDAnon-GAAPFY2026$385.00M – $395.00M–NewNov 4, 2026
adjusted EBITDAnon-GAAPFY2026$380.00M – $400.00M$370.00M – $395.00MRaisedJul 29, 2026
diluted adjusted EPSnon-GAAPFY2026$5.25 – $5.45–NewNov 4, 2026
diluted adjusted EPSnon-GAAPFY2026$5.00 – $5.45$4.70 – $5.20RaisedJul 29, 2026
Free cash flownon-GAAPFY2026$220.00M – $230.00M–NewNov 4, 2026
Free cash flownon-GAAPFY2026$220.00M – $245.00M$215.00M – $245.00MRaisedJul 29, 2026

Guidance vs results

The last range Ingevity gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2025Revenue$1.25B – $1.35B$1.27BΣ4QWithin range

Guidance history

Every forecast Ingevity put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 4, 2026adjusted EBITDAFY2026$385.00M – $395.00MNew
Nov 4, 2026diluted adjusted EPSFY2026$5.25 – $5.45New
Nov 4, 2026Free cash flowFY2026$220.00M – $230.00MNew
Nov 4, 2026net salesFY2026$1.10BNew
Jul 29, 2026adjusted EBITDAFY2026$380.00M – $400.00MRaised
Jul 29, 2026diluted adjusted EPSFY2026$5.00 – $5.45Raised
Jul 29, 2026Free cash flowFY2026$220.00M – $245.00MRaised
Jul 29, 2026net salesFY2026$1.05B – $1.15BReaffirmed
May 6, 2026adjusted EBITDAFY2026$370.00M – $395.00MLowered
May 6, 2026adjusted EPSFY2026$4.70 – $5.20Lowered
May 6, 2026Free cash flowFY2026$215.00M – $245.00MLowered
May 6, 2026net salesFY2026$1.05B – $1.15BLowered
Feb 25, 2026adjusted EBITDAFY2026$380.00M – $400.00MNew
Feb 25, 2026adjusted EPSFY2026$4.80 – $5.20New
Feb 25, 2026Free cash flowFY2026$225.00M – $250.00MNew
Feb 25, 2026net sal esFY2026$1.10B – $1.20BNew
Nov 5, 2025total adjusted EBITDAFY2025$390.00M – $405.00MNew
Nov 5, 2025total net salesFY2025$1.25B – $1.35BNew
Aug 4, 2025adjusted EBITDAFY2025$390.00M – $415.00MRaised
Aug 4, 2025salesFY2025$1.25B – $1.40BReaffirmed

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Ingevity filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Update
  5. Results
  6. Results
  7. Update
  8. Update
  9. Update
  10. Update
  11. Results
  12. Update
  13. Update
  14. Results
  15. Update

See a number that looks wrong?